Please enable JavaScript.
Coggle requires JavaScript to display documents.
THE FUTURE ROLE OF CARDIO-ONCOLOGISTS - Coggle Diagram
THE FUTURE ROLE OF CARDIO-ONCOLOGISTS
Cardiovascular disease and cancer
Survival of oncological patients can be limited by adverse effects
Intensive antitumorous treatment
Cardiotoxicity
Can negatively affect survival and quality of life
· May compromise the effectiveness of the anticancer therapy.
Depression of the left ventricle function
Heart failure in patients treated with anthracyclines
Cardiovascular disease complications
Myocardial dysfunction
Heart failure
Coronary artery disease
Valvular disease
Arrhythmias
Arterial hypertension
Thromboembolic disease
Peripheral vascular disease and stroke
Pulmonary hypertension and pericardial complications.
Cardiovascular disease risk factors
Current myocardial disease.
Demographic risk factors (age, family history of premature CV disease, arterial hypertension, diabetes mellitus).
Life-style risk factors.
Previous cardiotoxic cancer treatment.
Cardiovasular disease diagnosis
Echocardiography
Biomarker assessment
Nuclear cardiac imaging
MRI (LVF and structural changes of the myocardium)
ECG
